Cheer­ful mid-stage de­pres­sion drug da­ta send Ax­some stock fly­ing

On the same day Sage rolled out $SAGE tremen­dous oral drug da­ta in post­par­tum de­pres­sion, Ax­some Ther­a­peu­tics has an­nounced that its lead ex­per­i­men­tal CNS …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.